CLINICAL IMPORTANCE OF DISCORDANCE IN HORMONE RECEPTOR AND HER2/NEU STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER

Basit Öğe Kaydı
dc.authorid0000-0001-6126-5377
dc.contributor.authorUstaalioglu, B. B. Oven
dc.contributor.authorVardar, F. Aker
dc.contributor.authorBilici, A.
dc.contributor.authorGurleyik, G.
dc.contributor.authorErkol, B.
dc.contributor.authorKefeli, U.
dc.date.accessioned2025-05-10T19:38:39Z
dc.date.issued2014
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description39th ESMO Congress (ESMO) -- SEP 26-30, 2014 -- Madrid, SPAIN
dc.description.abstract[No abstract available]
dc.description.sponsorshipESMO
dc.identifier.doi10.1093/annonc/mdu328.5
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1093/annonc/mdu328.5
dc.identifier.urihttps://hdl.handle.net/20.500.14730/9422
dc.identifier.volume25
dc.identifier.wosWOS:000346901000176
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.ispartofAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.titleCLINICAL IMPORTANCE OF DISCORDANCE IN HORMONE RECEPTOR AND HER2/NEU STATUS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER
dc.typeConference Object

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
9422.pdf
Boyut:
67.85 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu